Efficacy and Safety of Pirfenidone Treatment in HPS-ILD

Clinical trial NCT04193592 · UNKNOWN

Trial details

NCT number: NCT04193592
Sponsor: Jesse Roman
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hermansky Pudlak Syndrome Interstitial Lung Disease

Start date: 2019-12-01
Primary completion: 2022-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.